Agenda - 2007 Oracle Pharmaceutical and Biotechnology Industry Forum

2007 Oracle Pharmaceutical and Biotechnology Industry Forum
Sheraton Philadelphia City Center, Philadelphia, PA
May 1-2, 2007

Agenda
Tuesday, May 1, 2007
	General Session (Liberty C)
8:15 a.m.	Registration and Breakfast
9:00 a.m.	Welcome Address Gonzalo Castro, Director, Oracle Life Sciences Product Strategy
9:05 a.m.	The Changing Pharmaceutical Industry P. Roy Vagelos, Former Chairman of the Board and Chief Executive Officer, Merck & Co. At a time when drug development is so critical to the healthcare system and has come under increased scrutiny, the need for a clear vision on what the future holds for medicine—as well as a critical assessment of the current environment, has taken a renewed interest among industry leaders. From his privileged vantage point, Mr. Vagelos will trace the history behind some of the industry’s current practices and provide thought-provoking insights on its current state.
9:45 a.m.	Oracle Life Sciences Product Direction Rajan Krishnan, Vice President, Oracle Life Sciences Product Strategy Oracle has delivered consistently positive business results in applications both from organic growth and acquisition-led growth, with a keen focus on industry verticals. The company continues to make substantial investments to develop its best of breed products, deliver integration between products, and develop a common application that brings together the best of the best from various assets to deliver innovative and powerful solutions that maximize business value for our customers. This session will feature Oracle's strategy and product direction for the Life Sciences industry.
10:20 a.m.	Solutions Pavilion (Liberty D)
	Track 1: CRM (Liberty C)	Track 2: Clinical (Philadelphia BR)
10:45 a.m.	Managing Information to Execute on Business Critical Decisions Gregg Ciarelli, Executive Director, Sales Administration, Boehringer Ingelheim This session will describe BI's framework for a guided analytics approach and how it can be leveraged for a successful implementation of a field management reporting system	Data Integration, Analysis, and Reporting with Oracle Life Sciences Data Hub Sharon Marmaras, Boehringer Ingelheim This presentation describes Boehringer Ingelheim's collaborative efforts with Oracle to develop an integrated system for clinical data integration, storage, analysis, and reporting on an international basis, which ultimately became Oracle's Life Science data Hub.
11:30 a.m.	Inflection Point Strategies: Enabling High-Performance through the Marketing and Sales Function in the US Biopharmaceutical Industry Tom Schwenger, Partner, Accenture The biopharmaceutical sector faces significant challenges—slumping investor confidence, pricing pressure, patent expiration, increasing compliance challenges, among others. Accenture's new research shows that organizations must move from the old ways of doing business to new approaches in order to remain competitive. This presentation will cover the results of surveys and interviews with executives from 18 major pharmaceutical and biotech organizations in North America, focusing on the capabilities required to succeed in the future.	How a Clinical Trial Management System can Improve Operational Efficiencies Jeff Conant, Program Manager, Genzyme This session will describe the challenges that the Clinical Research Group at Genzyme had to overcome to produce standards, efficiencies, planning capabilities and increased quality in a global environment, and how the Siebel CTMS application provided Clinical Research with the tool necessary to achieve its goals.
12:15 p.m.	Networking Lunch (Liberty B)
1:00 p.m.	Managing Lifetime Customer Relationships in a Highly Regulated Environment Mike Breggar, Director, Healthcare and Life Science Practice, Deloitte Consulting Managing Physician-related information and ensuring compliance throughout the drug life-cycle: R&D, Clinical Trials, KOL, Detailing, and Post-Market Vigilance. The major emphasis of this presentation will be on what the FDA is expecting in the future.	A Revolutionary Approach in Overcoming the Challenges of Clinical Data Aggregation Chris Moore, Partner, IBM Global Business Services, IBM Managing clinical data is an intricate and complex process within R&D. From collection to submission and to broader data reuse, there are many relevant players and stakeholders. These individuals are impacted by the frequent influx of changes in process and technology. IBM will address these issues in a presentation that will cover the current environment, the 2010 vision of the future, and the need for clinical data aggregation.
1:45 p.m.	Territory Realignments as a Driver for Business Agility Joshua Hughes, Director, CRM Solution Delivery, Johnson & Johnson Michael Comprelli, Manager, CRM Business Relationship Manager, Johnson & Johnson Within the context of a corporate-wide CRM strategy, Johnson & Johnson implemented Oracle's Territory Management module to provide greater leverage of J&J’s CRM suite by enabling business efficiencies to their current alignment process and enabling new capability in managing organizational sales hierarchies. Business benefits, challenges and future direction will be discussed.	Managing Adverse Events in the Post Market World Andrew Winkler, Director of Applications, Sepracor Faced with several challenges, such as changes in business organization and processes, exponential increases in case volume as new products were introduced, and a transition to an in-house case triage and process, Sepracor decided to implement Oracle's Adverse Events and Reporting System. This session will describe Sepracor's implementation and highlight the results achieved, benefits, and future direction.
2:30 p.m.	Implementing a Samples Management Solution Larry Fisher, Associate Director, Business Information Systems, Astellas US Astellas has implemented Siebel Samples Management to distribute samples and capture electronic signatures on handheld devices. This session will describe the key elements of this implementation, as well as some of the benefits and lessons learned.	Implementing a Remote Data Capture Solution James Streeter, Executive Director of EDC, PPD As the Pharma industry has turned the corner with the use of EDC being widely used and accepted, OC RDC can provide the foundation and technology for making EDC successful. This presentation will cover the primary business drivers, implementation factors, and results with implementing the use of OC RDC and show the values of implementing EDC within the pharmaceutical industry.
3:15 p.m.	Solutions Pavilion (Liberty D)
	General Session (Liberty C)
3:30 p.m.	The Process View of Innovation Karl Ulrich, Professor and Chairperson, Operations and Information Management, The Wharton School Innovations as diverse as motion pictures, pharmaceuticals, consumer products, and software can be usefully thought of with a single framework. Mr. Ulrich calls this framework the "process view of innovation." Within the process view, innovations begin as hypotheses that value can be created and end with the realization of that value. When thought of this way, many useful analogies with manufacturing processes can be made, including notions of flow rate, flow time, capacity utilization, and yield loss. In this talk, Mr. Ulrich will introduce the Process View, show some key insights, and apply these insights to pipeline management in the pharmaceutical industry.
4:15 p.m.	IT Effectiveness - Streamlining Product Delivery To Market Eric Newmark, Senior Research Analyst, IDC Health Industry Insights Product time-to-market and consumer accessibility are top of mind for the life science industry. This presentation will discuss how IT is helping to streamline business processes in the clinical environment and increase the efficiency of pharmaceutical sales forces so drug manufacturers can better reach end consumers.
5:00 p.m.	Cocktail Reception and Networking (Liberty D)
Wednesday, May 2, 2007
8:15 a.m.	Breakfast and Solution Pavilion (Liberty D)
	General Session (Liberty C)
9:00 a.m.	Oracle Applications Vision and Strategy John Wookey, Senior Vice President, Oracle Applications Division Through continued innovation, strategic acquisitions and a unique industry vision, Oracle's applications business has greatly expanded the possibilities for customers to better compete, execute, and adapt. Come hear how Oracle Applications deliver greater business insight, deep, adaptive industry processes, and a superior ownership experience that embraces many of the hottest trends in the marketplace, such as SOA, Web 2.0, among others.
9:40 a.m.	Understanding How Patients and Physicians Use Emerging Technologies to Access Information Mark Bard, President & Co-Founder, Manhattan Research The information and media landscape has shifted over the past 10 years; patients and physicians control when, where, and how they access clinical and education content. This session will review why electronic "touch points" and digital assets must be integrated within the overarching sales and marketing strategy.
10:20 a.m.	Solution Pavilion (Liberty D)
	Track 1: CRM (Liberty C)	Track 2: Mfg and Supply Chain (Phila. BR)
10:45 a.m.	Implementing a Multi-Channel, Customer-Centric Engagement Model Hima Patel, Executive Director, Merck & Co. The pharmaceutical commercial model is being challenged by multiple environmental conditions, the changing role of multiple customer groups and the increase viability of alternative channels of communications. In order to address these challenges, Merck implemented a customer-centric approach for interacting with health care providers and patients. The designed solution focuses on business and technology competencies which are integrated across marketing, sales, and service.	Implementing a Global Model for Sales and Operations Planning Perry Cozzone, VP & CIO, Colorcon Attend this session to learn about Colorcon's global implementation of the Oracle E-Business Suite on a single instance to better serve its many pharmaceutical industry customers (it's likely that you are one). The global single instance has yielded benefits in rationalizing planning and operational processes worldwide and providing accurate business information which enables informed decisions.
11:30 a.m.	Breaking Organizational Silos Through Streamlined Information Flow Srivatsan Nagaraja, Vice President, Life Sciences Practice, Cognizant Life Sciences organizations face significant challenges to improve throughput of the R&D pipeline, to transform their manufacturing operations to be more demand-driven, and to make their commercialization efforts more customer-focused. The lack of standardization has led to data and informational silos. In this presentation, Cognizant will present an architecture that helps organizations streamline information from all areas and provide a model to establish individual analytic infrastructures across the pharmaceutical value chain.	Supply Chain Management & Manufacturing for Life Sciences John Danese, Product Strategy Director, Oracle Today's increased margin pressures are forcing industry to understand and be driven by the true nature of the demand for its products and how to satisfy that demand in the most efficient way possible. Attend this session to learn about Oracle's strategy to enable closed loop sales and operations planning and integrated manufacturing for life science industries.
12:15 p.m.	Networking Lunch (Liberty B)
1:00 p.m.	Delivering Effective Responses to Medical Information Requests Carmella Schmit, Director, sanofi-aventisNicholas Pentz, Technical Lead, sanofi-aventis At sanofi-aventis, the Medical Information and Customer Service departments use Siebel to compose and deliver custom response letters. This session will describe the technology implemented to facilitate this process, a solution referred to as the Response Composer	Outsourcing Pharmaceutical Manufacturing Joe McGrath, Vice President, Information Technologies, Sepracor Most small and medium life science and pharmaceutical companies have outsourced many aspects of their product supply, manufacturing, and sales/distribution operations, choosing to focus on what they do best, product research and development. Sepracor Inc. successfully uses the Oracle 11i Business Suite to manage the data flows and transactions related to this outsourcing, without ever touching the materials or products, in a multiple partner environment.
1:45 p.m.	Facilitating Meaningful Customer Interactions with Oracle Real Time Decisioning Nicolas Bonnet, Product Management Director, Oracle Oracle Real Time Decisioning (RTD) enables organizations to deliver rich customer interactions by providing customer-facing personnel with contextual information gathered at the point of contact. This session will describe the technology behind RTD and will feature a practical application.	Leveraging World Class Technology to Address Electronic Pedigree Requirements in Life Sciences David Stokes, Business and Decision In this session B&D will introduce a flexible and robust framework, developed in partnership with Oracle and utilizing Oracle technology and applications, to enable drug chain of custody tracking and traceability throughout the supply chain
2:30 p.m.	Solution Pavilion (Liberty D)
3:00 p.m.	Effectively Deploy Pharma 7.8 and Analytics Vyom Bhuta, Director, Sales Operations, Otsuka	The Secure Supply Chain: Track, Trace, and Authenticate Rolando de Cardenas, VP of Pharmaceutical Distribution, US Oncology Don Birk, Deloitte Consulting
3:45 p.m.	Siebel Life Sciences 8.2 Preview Gonzalo Castro, Product Strategy Director, Oracle Pankesh Jhaveri, Product Strategy Director, Oracle This session will introduce some of the features planned for the next release of Siebel Life Sciences (v 8.2). Short demos of these features will be presented.	Orchestrating Business Integration Using Oracle BPEL Process Manager Brian Conneen, Principal Solutions Architect, Oracle BPEL Process Manager is a plug-and-play, standards-based infrastructure for integrating systems, services and people activities into easy-to-change process flows. Join this session to learn how it can help your organization deliver composite applications as well as data integration applications.
4:30 p.m.	Prize Draw and Closing Remarks (Liberty C)

ORACLE LIFE SCIENCES

5820